| Hematopoietic and Lymphatic System Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 342show all (up to 200) |
|---|
| → investigated in trials for | Dexamethasonesmall molecule 873 trials (266 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 873 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 852 trials (209 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 852 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 707 trials (138 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 707 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 658 trials (153 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 658 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 507 trials (157 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 507 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 450 trials (99 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 450 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 383 trials (158 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 383 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 365 trials (226 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 365 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 329 trials (82 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 329 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 313 trials (52 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 313 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 305 trials (51 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 305 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 303 trials (58 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 303 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 256 trials (41 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 256 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 248 trials (20 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 248 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 223 trials (64 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 223 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 220 trials (119 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 220 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daunorubicinsmall molecule 194 trials (47 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 194 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 193 trials (80 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 193 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 190 trials (56 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 190 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 187 trials (48 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 187 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 186 trials (59 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 186 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 175 trials (68 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 175 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 163 trials (29 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 163 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 121 trials (12 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 121 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 103 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 103 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 99 trials (26 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 99 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 97 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 97 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 84 trials (24 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 84 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemtuzumab Ozogamicinadc 83 trials (15 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 83 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 78 trials (14 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 78 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 78 trials (13 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 78 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 77 trials (24 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 77 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 76 trials (13 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 76 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 73 trials (18 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 73 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 73 trials (37 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 73 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 73 trials (22 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 73 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 72 trials (34 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 72 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 70 trials (13 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 70 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 69 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 69 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 67 trials (14 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 63 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 63 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 63 trials (43 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 63 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belantamab Mafodotinadc 60 trials (40 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 60 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 59 trials (14 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 59 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 58 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Isatuximabmonoclonal antibody 58 trials (45 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 57 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 57 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elotuzumabmonoclonal antibody 57 trials (18 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 57 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thioguaninesmall molecule 57 trials (12 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 57 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 54 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 53 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 50 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gilteritinibsmall molecule 50 trials (26 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 49 trials (15 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 48 trials (12 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teclistamabmonoclonal antibody 46 trials (42 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elranatamabmonoclonal antibody 44 trials (35 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 44 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 43 trials (9 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 38 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 37 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 37 trials (9 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 37 trials (18 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Midostaurinsmall molecule 35 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 35 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 34 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talquetamabmonoclonal antibody 32 trials (27 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 31 trials (9 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Quizartinibsmall molecule 31 trials (10 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 30 trials (10 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 30 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 29 trials (20 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 27 trials (8 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 26 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 26 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ivosidenibsmall molecule 25 trials (20 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 25 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 25 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 24 trials (13 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 24 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 23 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nilotinibsmall molecule 23 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Revumenibsmall molecule 23 trials (18 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 22 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxyureasmall molecule 22 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 22 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 22 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 21 trials (10 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 20 trials (17 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inotuzumab Ozogamicinadc 20 trials (14 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mogamulizumabmonoclonal antibody 20 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 20 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 20 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 19 trials (16 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Omacetaxine Mepesuccinatesmall molecule 19 trials (8 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 18 trials (14 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tagraxofuspother 18 trials (11 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 17 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Treosulfansmall molecule 17 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 16 trials (10 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linvoseltamabmonoclonal antibody 16 trials (14 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 16 trials (9 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Calaspargase Pegolother 15 trials (13 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 15 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 14 trials (10 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 13 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idecabtagene Vicleucelgene therapy 13 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pacritinibsmall molecule 13 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bosutinibsmall molecule 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ropeginterferon Alfa-2bother 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Volasertibsmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ziftomenibsmall molecule 12 trials (11 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Duvelisibsmall molecule 11 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glasdegibsmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nirogacestatsmall molecule 11 trials (8 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall molecule 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 10 trials (9 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avapritinibsmall molecule 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bexarotenesmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lisocabtagene Maraleucelgene therapy 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Loncastuximab Tesirineadc 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ciltacabtagene Autoleucelgene therapy 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Donor Lymphocyte Infusion 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Navtemadlinsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olutasidenibsmall molecule 7 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amsacrinesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlorambucilsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crenolanibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dacarbazinesmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinaciclibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hematopoietic Cell Transplantation 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Odronextamabmonoclonal antibody 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Barasertibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lestaurtinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalan Flufenamidesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mocetinostatsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2bother 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asciminibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azathioprinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bleomycin 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HyperCVAD Regimen 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rigosertibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphatic System Neoplasm | 3 | Observed | clinicaltrials | graph → |